Year-over-year earnings per share growth for the last twelve months: cardiodiagnosticsinc.com (CDIO)
The large-scale implementation of AI algorithms for DNA marker analysis may spark skepticism, yet the quarterly EPS trend confirms management effectiveness. The value of 39.60 reflects the current profit magnitude, reinforcing Cardio Diagnostics (CDIO) as a cardiology innovator with a proprietary platform. The ability to identify myocardial infarction risk via blood epigenetics enables the prevention of catastrophes, radically outpacing traditional diagnostic methods.
Cardio Diagnostics (CDIO) - metric breakdowns and financial figures
- share price and expert price forecast:
- company stock exchange capitalization indicators:
- book capitalization data:
- debt level and financial liquidity data:
Debt to Equity Cardio Diagnostics|CDIO - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital cardiodiagnosticsinc.com|CDIO - Company Aggregate Debt|Debts to Book Capitalization Cardio Diagnostics|CDIO - Long-Term Debt Volume|Company Short-Term Debt Cardio Diagnostics|Quick Liquidity Indicator cardiodiagnosticsinc.com
- earnings and valuation multiples indicators:
CDIO - Final Profit|Projected Future Earnings Cardio Diagnostics|CDIO - Price to Earnings Multiple|Forward P/E Multiple cardiodiagnosticsinc.com|CDIO - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Cardio Diagnostics|CDIO - Operating profit EBITDA|Net earnings per share (EPS TTM) Cardio Diagnostics|CDIO - Net earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months cardiodiagnosticsinc.com|CDIO - Earnings per share growth this year|Net earnings per share growth forecast for next year Cardio Diagnostics
Summary company analysis:Cardio Diagnostics Holdings Inc. - CDIO
The commercial success of Cardio Diagnostics (CDIO) in the field of AI epigenetics and early myocardial infarction diagnostics translates directly into net earnings per share. The trajectory of quarterly EPS growth visualizes the dynamics of the business's actual cash flows, allowing investors to assess the efficiency of scaling innovations and determine the company's capital stability relative to market expectations.
Competitors of Cardio Diagnostics (CDIO)
A: Quarterly EPS earnings growth|DGX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Illumina Corp|Exact Sciences Inc. (EXAS) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth RVTY|Year-over-year net earnings per share growth for the last 12 months bio-rad.com BIO|Quarterly EPS earnings growth NNNN (Anbio)|Quarterly EPS earnings growth Sotera Health Corp SHC|QDEL - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months OPK (OPKO Health Corp.)|CDNA: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months MRVI|FLGT (Fulgent Genetics) - Quarterly EPS earnings growth|Standard BioTools Inc (LAB) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Cytek Bio (CTKB)|OSUR - Earnings per share growth in annualized terms for the last twelve months|Exagen - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months MDXH|Lucid Diagnostics - Quarterly EPS earnings growth|PRE (Prenetics Global) - Year-over-year earnings per share growth for the last 12 months|IMDX: Quarterly EPS earnings growth|TRIB - Year-over-year net earnings per share change for the last twelve months|PRPH (ProPhase Labs, Inc.) - Quarterly EPS earnings growth|Quarterly EPS earnings growth ainos.com|Quarterly EPS earnings growth CODX|Heart Test Laboratories, Inc. (HSCS) - Net earnings per share growth for the trailing year|Year-over-year earnings per share growth for the last twelve months Biomerica, Inc BMRA|ONCO: Year-over-year earnings per share growth for the last 12 months|VRAX - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months bluejaydx.com|Aspira Women's Health Inc. (AWH) - Year-over-year earnings per share growth for the last twelve months|AXDX - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months CNTG|ENZ (Enzo) - Year-over-year earnings per share growth rate for the last twelve months|Quarterly EPS earnings growth FRES|Year-over-year net earnings per share change for the last twelve months gtglabs.com|Quarterly EPS earnings growth ME (23andMe)|PMD - Year-over-year net earnings per share growth for the last 12 months
